Related Experiment Video

Updated: Jul 15, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?

Fatima Akdim1, Sander I van Leuven, John J P Kastelein

  • 1Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.

Current Pharmaceutical Design
|April 14, 2007
PubMed

Insights

Statins reduce cardiovascular events by stabilizing vulnerable plaques, not just by lowering cholesterol. This review explores plaque vulnerability and statins' plaque-stabilizing effects.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Acute coronary syndromes (ACS) are a leading cause of death globally.
  • Lipid-lowering therapies show significant risk reduction for cardiovascular events.
  • A discrepancy exists between reduced events and modest changes in stenosis, suggesting plaque stabilization as a key mechanism.

Purpose of the Study:

  • To review determinants of plaque vulnerability in ACS.
  • To discuss the plaque-stabilizing, or pleiotropic, effects of statin treatment.

Main Methods:

  • Review of existing literature on ACS, plaque vulnerability, and statin mechanisms.
  • Analysis of studies demonstrating statin effects beyond lipid lowering.

Main Results:

  • Statins inhibit cholesterol biosynthesis, leading to lipid level reduction.
  • Statins exhibit pleiotropic effects, including inflammation modulation and improved endothelial function.
  • These pleiotropic effects contribute to the stabilization of vulnerable atherosclerotic plaques.

Conclusions:

  • Statin therapy offers cardiovascular benefits through both lipid-lowering and plaque-stabilizing mechanisms.
  • Understanding plaque vulnerability is crucial for managing ACS.
  • Pleiotropic effects of statins play a significant role in reducing recurrent cardiovascular events.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Inflammation01:38

Inflammation

Overview